SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0000921895-20-001187
Filing Date
2020-04-24
Accepted
2020-04-24 16:50:45
Documents
5

Document Format Files

Seq Description Document Type Size
1 prec14a09488034_04242020.htm PREC14A 189640
2 GRAPHIC image_001.jpg GRAPHIC 3606
3 GRAPHIC image_002.jpg GRAPHIC 3594
4 GRAPHIC image_003.jpg GRAPHIC 3603
5 GRAPHIC image_005.jpg GRAPHIC 39801
  Complete submission text file 0000921895-20-001187.txt   261758
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-36500 | Film No.: 20815744
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1370 BROADWAY 5TH FLOOR NEW YORK NY 10018
Business Address 1370 BROADWAY 5TH FLOOR NEW YORK NY 10018 (212) 321-0048
ENGINE CAPITAL, L.P. (Filed by) CIK: 0001580320 (see all company filings)

IRS No.: 364755478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A